In chronically treated Zucker diabetic fatty rats, (63) also reduced hepatic steatosis, enhanced glucose-stimulated insulin secretion and lowered hemoglobin A1c by 0.9% [213]. The gene discussed is INS; the disease is fatty liver disease.